Birdwatch Archive

Birdwatch Note Rating

2025-02-16 11:31:23 UTC - NOT_HELPFUL

Rated by Participant: 82903CFFB4EA1002C0A238A60A0671B9D04F04B2EB5DC70771029FCCFACD76C6
Participant Details

Original Note:

China’s advancements in diabetes treatment are promising, their integration into U.S. medical practice depends on thorough validation through clinical trials and regulatory approval. The suggestion that financial motivations are hindering adoption lacks substantiated evidence. https://medium.com/%40thechinaacademy/chinas-diabetes-cure-america-s-last-hope-15f231cdaec6

All Note Details

Original Tweet

All Information

  • noteId - 1890855351509221687
  • participantId -
  • raterParticipantId - 82903CFFB4EA1002C0A238A60A0671B9D04F04B2EB5DC70771029FCCFACD76C6
  • createdAtMillis - 1739705483626
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - NOT_HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 0
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 0
  • helpfulImportantContext - 0
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 1
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 1
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 1
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 189085535150922168782903CFFB4EA1002C0A238A60A0671B9D04F04B2EB5DC70771029FCCFACD76C6